Table 2.
Primary antibody | Specificity | Antigen retrieval | Dilution/incubation time | Source | Reference |
ESEE 122 | HIF-1α | 0.1 m EDTA 3 min, PC | Neat 90 min, RT | In house | 27 |
EP 190b | HIF-2α | 0.1 m EDTA 60°C, ON | Neat 90 min, RT | In house | 27 |
CW27 | DEC-1 | Citrate buffer 10 min, MW | 1:1000 45 min, RT | Prof. Adrian Harris, CRUK | 18 |
VG-1 | VEGF | 0.05 m Tris/0.2 mm EDTA 3 min, PC | 1:4, 90 min, RT | In house | 28 |
C-17 | VEGF-R1 | As above | 1:200 90 min, RT | Santa Cruz, CA | |
Y-23 | VEGF-R2 | As above | 1:200 90 min, RT | Santa Cruz, CA | |
pKDR34 | pKDR | Citrate buffer 3 min, MW | 1:5 90 min, RT | In house | 29 |
All primary antibodies were visualized with the Envision-HRP/AP kits (Dako, Ely, UK) with the exception of ESEE 122, which was visualised with the TSA-HRP kit (NEN, Boston, MA, USA).
EDTA, ethylenediamine tetraaceticacid; ON, overnight; RT, room temperature; PC, pressure cooker; MW, microwave; CRUK, Cancer Research, UK.